← Scoopfeeds — Intelligent news, curated.
Mirum Pharmaceuticals (MIRM) Reports Positive Phase 2b Data for Volixibat in PSC at EASL Congress
business

Mirum Pharmaceuticals (MIRM) Reports Positive Phase 2b Data for Volixibat in PSC at EASL Congress

Yahoo Finance · Jun 4, 2026, 9:06 AM · Also reported by 1 other source

Mirum Pharmaceuticals (MIRM) Reports Positive Phase 2b Data for Volixibat in PSC at EASL Congress

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Edesa reports exploratory data on AKI treatment candidate

More in business

BBC Business
Free Thinking
Investing.com
LZ Technology Holdings appoints Huijuan Xu as independent director after resignation
Investing.com
Form 144 Five9 For: 5 June
Investing.com
Form 144 ANI PHARMACEUTICALS For: 5 June
Investing.com
Form 144 Flywire Corporation For: 5 June
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop